Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
Enhertu significantly improved progression-free survival in DESTINY-Breast03 head-to-head trial vs. trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer
-
Saphnelo (anifrolumab) approved in the US for moderate to severe systemic lupus erythematosus
-
H1 2021 results
-
Vaxzevria and mRNA COVID-19 vaccines showed similar and favourable safety profiles in a population-based cohort study of over a million people
-
Vaxzevria showed no increased incidence of thrombosis with thrombocytopenia after second dose
-
AstraZeneca and Regeneron to research, develop and commercialise new small molecule medicines for obesity
-
Ultomiris recommended for approval in the EU by CHMP for children and adolescents with paroxysmal nocturnal haemoglobinuria
-
Vaxzevria is highly effective after one dose against severe disease or hospitalisation caused by Beta and Delta variants of concern
-
Acquisition of Alexion completed
-
Imfinzi approved in China for the treatment of extensive-stage small cell lung cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here
